Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Acidosis, Diabetic

triazoles has been researched along with Acidosis, Diabetic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Filler, SG; French, SW; Gebremariam, T; Ibrahim, AS; Lee, H; Luo, G; Patterson, TF; Wiederhold, NP1
Costantino, F; Di Biasi, C; Friederici, D; Notheis, G; Pasquino, AM; Tarani, L; Venditti, M; Wintergerst, U1
Edwards, JE; Gebremariam, T; Ibrahim, AS; Schwartz, JA; Spellberg, B1
Curto, CL; Danvin, JB; Dessi, P; Mimouni, O; Thomassin, JM1
Edwards, JE; Ibrahim, A; Reed, C; Spellberg, B; Walot, I1

Other Studies

5 other study(ies) available for triazoles and Acidosis, Diabetic

ArticleYear
Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Cortisone; Cyclophosphamide; Diabetic Ketoacidosis; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Mice, Inbred NOD; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Triazoles

2013
Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl.
    Pediatric diabetes, 2009, Volume: 10, Issue:4

    Topics: Antifungal Agents; Central Nervous System Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Follow-Up Studies; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; Time Factors; Treatment Outcome; Triazoles

2009
Posaconazole mono- or combination therapy for treatment of murine zygomycosis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Diabetic Ketoacidosis; Dose-Response Relationship, Drug; Drug Combinations; Kidney; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rhizopus; Triazoles; Zygomycosis

2009
Sinonasal mucormycosis: case report.
    European annals of otorhinolaryngology, head and neck diseases, 2010, Volume: 127, Issue:1

    Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diabetes Complications; Diabetic Ketoacidosis; Endoscopy; Ethmoid Sinusitis; Humans; Infusions, Intravenous; Male; Mucormycosis; Opportunistic Infections; Rhinitis; Tomography, X-Ray Computed; Triazoles

2010
Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11

    Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Brain Stem; Caspofungin; Cavernous Sinus; Central Nervous System Fungal Infections; Deferasirox; Diabetic Ketoacidosis; Drug Therapy, Combination; Echinocandins; Humans; Iron Chelating Agents; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Peptides, Cyclic; Salvage Therapy; Triazoles

2006